National sponsor of the Motherisk Program
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Consortium of Cancer in Pregnancy Evidence (CCoPE)
Paolo Mazzotta, M.Sc.Psychopharmacology Research Program Sunnybrook Health Science Centre, Toronto
Paolo Mazzotta completed his Bachelor and Master of Science degrees in Toxicology and Pharmacology from the University of Toronto. His graduate work focused on issues pertaining to nausea and vomiting of pregnancy (NVP), which included documenting the potential association between NVP and elective termination of pregnancy, the effect of counseling on teratogenic risk perception of antiemetics in women with NVP and, more recently, the development of a health-related quality of life questionnaire for women with NVP. Paolo's work has been presented at a number of international meetings in addition to publishing several articles on the topic of NVP and the effects of pharmacological agents on human pregnancy.
Cancer In Pregnancy Website Article:
Pharmacological and non-pharmacological treatment of chemotherapy-induced nausea and vomiting
![[Valid RSS]](/images/rssValid.png "Validate my RSS feed")